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Infection of tobacco protoplasts with mutant alfalfa mosaic virus (AMV) RNAs indicated that three basic amino acids in the
N-terminus of AMV coat protein are important for the biological activity of the coat protein in the beginning of infection.
Substitution of alanines for lysines at position 14 or 17 in the coat protein resulted in a 5- or 10-fold reduction in the activity
of the protein, respectively. However, substitution of alanine for arginine at position 18 entirely abolished activity. Arginine 18
was also required for the coat protein to bind to the 39 noncoding region of the virus RNA in vitro, whereas lysine 14 or 17
was not required. Thus, these results indicate that arginine 18 is essential for the activity of the coat protein in early infection
and that binding of the coat protein to AMV RNA correlates with activity. © 1998 Academic Press
Specific RNA–protein interactions are essential for
many biological processes, including transactivation of
transcription (Dingwall et al., 1989; Puglisi et al., 1992),
RNA replication (Pogue et al., 1990), and virion assembly
(Chen et al., 1989). A unique protein–RNA interaction is
required for the replication of alfalfa mosaic virus (AMV)
(Bol et al., 1971; Jaspars, 1985). The three genomic RNAs
of these viruses are not infectious alone, but require the
coat protein (CP) for infection (Bol et al., 1971). Possible
roles of the AMV CP in such ‘‘genome activation’’ include:
(1) stabilizing the viral genomic RNAs (Loesch-Fries et
al., 1985; Neeleman et al., 1993), (2) forming an active
replicase complex with other AMV proteins and putative
host proteins (Quadt et al., 1991), and (3) inducing a
switch from virus minus- to plus-strand RNA synthesis
(van der Kuyl et al., 1991a,b; van der Vossen et al., 1994;
de Graaff et al., 1995). It has long been known that the
N-terminus of the CP is required for activating replica-
tion, although the mechanism for the activation is not yet
fully understood. Presumably, binding of the CP to the 39
nucleotides of the viral RNAs is required (Bol et al., 1971).
The single-stranded AUGC repeats in the 39 ends of the
viral RNAs and three basic amino acids are required for
CP–RNA interactions (Houser-Scott et al., 1994; Reusken
et al., 1994; Yusibov and Loesch-Fries, 1995). In the
present work we investigated the importance of each of
the three amino acids in AMV infection and RNA binding.
RESULTS AND DISCUSSION
Genome activation
In vitro transcripts (Fig. 1) are designated rCP14A,
rCP17A, and so forth to distinguish them from the parent
plasmids. When assayed in a cell-free translation sys-
tem, all of the transcripts directed the synthesis of
polypeptides of the expected size (Fig. 2). The incorpo-
ration of [35S]Met was similar for all constructs, which
suggested that wt and mutant CPs were synthesized
with the same efficiency (data not shown).
To determine the biological activity of the mutant CPs,
tobacco protoplasts were inoculated with AMV RNAs 1,
2, and 3 alone or in combination with wt or mutant RNA4
transcripts (Samac et al., 1983). The mixture of genomic
RNAs alone did not result in infection (Fig. 3, bar 2),
whereas the addition of wt RNA4 transcripts resulted in
infection of 45% of the protoplasts (shown as 100% rela-
tive percentage infection, Fig. 3, bar 1). The addition of
rCP14A or rCP17A mutant transcripts resulted in relative
rates of infection of 21% (bar 3) or 12% (bar 4), respec-
tively. However, the inoculum containing rCP18A tran-
scripts was not infectious (bar 5). Similarly, the inoculum
containing rCP14, 18A or rCP17, 18A transcripts was not
infectious (bars 6 and 7, respectively).
To correlate the percentage of infection with the ac-
cumulation of viral RNA, total RNA was isolated from
inoculated protoplasts and assayed by Northern blot
hybridization, followed by autoradiography (Loesch-Fries
et al., 1987). Protoplasts inoculated with genomic RNA
plus rCP18A or rCP14, 17, 18A transcripts did not contain
detectable amounts of AMV RNA (Fig. 3B), which is
consistent with the results of the immunoassay (Fig. 3A)
and with previous results (Yusibov and Loesch-Fries,
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1995). When rCP14A was included in the inoculum, the
protoplasts accumulated 21% of the AMV RNA that ac-
cumulated in protoplasts inoculated with wt RNAs. Like-
wise, inclusion of rCP17A transcripts in the inoculum
resulted in the accumulation of 9% of the control RNA.
These results demonstrate that, of the 6 basic amino
acids in the first 25 N-terminal amino acids of CP, only
arginine 18 is absolutely required for infection. However,
lysine 14 and lysine 17 contribute to the full biological
activity of the CP. Lysines also occur at positions 5 and
6 in wt CP. The mutant, CPDN9 that lacks these lysines
and 7 surrounding amino acids, had about 73% of wt
activity in infection (Yusibov and Loesch-Fries, 1995).
Therefore, all lysines in the first 25 amino acids contrib-
ute to the biological activity of AMV CP, although none is
critical. The lysines contribute to the overall charge den-
sity in the N-terminus of the AMV CP, which is likely to be
important for its interaction with AMV RNA. This may be
similar to the importance of the charge density in the
HIV-1 Tat protein for its interaction with the TAR RNA
(Calnan et al., 1991). In the N-terminus of AMV CP, argi-
nine occurs at position 26 in addition to position 18.
Previous results indicated that amino acids 12–19 of the
CP were required for the activity of the CP in infection,
which suggested that arginine 26 is not sufficient for
activity. The results presented here confirm that the ar-
ginine at position 18 is critical.
AMV CP–RNA interaction
Peptides consisting of 25 or 38 amino acids corre-
sponding to the N-terminus of AMV CP bind to AMV RNA
39 ends and initiate infection (Baer et al., 1994). To de-
termine whether the activity of full-length CP mutants
correlated with an ability to bind to AMV RNA, 32P-
labeled RNA transcripts of 192 nucleotides correspond-
ing to the 39 end of RNA4 were incubated with the in vitro
translation products of wt and mutant RNA4, followed by
FIG. 1. Mutations in the AMV CP gene. The deduced amino acid sequence of the CP is indicated below the diagram of pSP65A4, which contains
cDNA to wt RNA 4. The CP ORF is indicated by the black box; the SP6 promoter is indicated by the open box. Sequences of the NheI and BsaI sites
introduced during cloning are underlined. Bold type indicates changes in the amino acid and nucleotide sequences and the ATG codons.
FIG. 2. SDS–PAGE electrophoresis of AMV CP mutants synthesized
in vitro. Proteins were labeled with [35S]Met in a wheat germ cell-free
translation system and separated by electrophoresis in a 13% SDS–
polyacrylamide gel followed by autoradiography. The lanes of the gel
are labeled with the RNA transcript used for translation. The position of
wt CP is indicated to the left.
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electrophoresis and autoradiography as described by
Baer et al. (1994). The translation products are desig-
nated CP14A, CP17A, and so forth to distinguish them
from the transcripts. A band shift occurred as expected
when the translation products of wt RNA4, wt CP, were
incubated with the RNA transcripts (Fig. 4, lane 2). Like-
wise, a band shift occurred when CP14A or CP17A was
incubated with AMV RNA (Fig. 4, lanes 5 and 6), indicat-
ing that the mutant CPs bound to the transcript. No band
shift occurred when CP18A, CP14, 18A, CP17, 18A, or
CP14, 17, 18A was added to the reaction. Similarly, no
band shift occurred when wt CP was incubated with
tobacco mosaic virus RNA (Fig. 4, lane 9). Thus, only
those CPs with arginine at position 18 bound to AMV
RNA. These results, taken together with the infectivity
assays, indicate that AMV CP must bind to the virus RNA
for infection to start. Recently, Ansel-McKinney et al.
(1996) reported that arginine 18 was a key amino acid in
a newly identified RNA binding motif in AMV CP. Using
amino-terminal peptides with substitutions at the lysines
and arginines, experiments showed that arginine 18 was
crucial for peptide–RNA binding. Our results presented
here extend the results to full-length CP. And our results
indicate that the CP binding motif is critical for the bio-
logical activity of AMV.
AMV coat protein was detected in replicase com-
plexes from infected plants along with the two largest
virus proteins, P1 and P2 (Quadt et al., 1991). The repli-
case complexes directed the in vitro synthesis of minus-
or plus-strand AMV RNA depending upon the template
(de Graaff et al., 1995). Replicase complexes free of AMV
CP were effective in directing the synthesis of plus- to
minus-strand RNA but ineffective in minus- to plus-strand
synthesis. The addition of CP to the reaction stabilized
the replicase complexes and stimulated plus-strand syn-
thesis fivefold. Similar results were found in vivo; a func-
tional CP gene was required for RNA plus-strand synthe-
FIG. 3. The biological activity of wt and mutant AMV CPs. (A) Genome activation. AMV RNAs 1, 2, and 3 (0.5 mg/105 protoplasts) were mixed with
wt RNA 4 or mutant transcripts (2.0 mg/105 protoplasts) and inoculated to tobacco protoplasts. Infected protoplasts were identified by an immunoassay
that detects large amounts of CP made during virus replication but not the early CP synthesized from wt RNA 4 or mutant transcripts. The legend to
the right indicates the specific RNA transcript used for genome activation; (2) indicates that no RNA transcript was added to the AMV genomic RNAs.
The bars indicate the average percentage of protoplasts that were infected in five or more experiments; the standard deviations are indicated. (B)
AMV RNA accumulation in tobacco protoplasts inoculated as described above. Total RNA was isolated from inoculated protoplasts, separated by
electrophoresis in an agarose gel, and detected by hybridization of cDNA probes corresponding to AMV RNAs 1, 2, and 3. The specific RNA transcript
added to the inoculum is indicated above the lanes and the relative percentage of RNA accumulation is indicated below the lanes.
FIG. 4. Electrophoretic mobility shift assay of CP–RNA complexes.
The 39 noncoding region of wt RNA 4 (192 nucleotides) was transcribed
from pSP65A4 and labeled in vitro. The labeled RNA (2 pmol) was
incubated for 10 min at room temperature with unlabeled translation
products of wt RNA 4 (CP) or mutant transcripts, followed by electro-
phoresis through a 7.5% polyacrylamide gel and autoradiography. The
lanes are labeled with wt CP or the mutant CP that was incubated with
the AMV RNA; (2) indicates that no AMV CP was added to the RNA.
The sample in lane 9 contained wt CP incubated with TMV RNA
transcript (a 59 fragment 500 nucleotides long). The sample in lane 10
contained wt CP that was incubated with unlabeled AMV RNA prior to
the addition of labeled AMV RNA. The position of free AMV RNA is
indicated at the left.
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sis (van der Vossen et al., 1994). Our results show that a
single amino acid substitution that prevents binding of
the CP to RNA abolishes infection. Thus, the role of the
CP in promoting plus-strand synthesis must involve its
interaction with the 39 end of AMV RNAs because the CP
does not interact with the minus-strand RNA (Jaspars,
1985). It is likely that, when P1 and P2 bind at the 39 end
of AMV RNA to form a replicase complex, the CP be-
comes part of the complex, thereby altering the complex
so that it favors copying minus templates rather than plus
templates. Neither the mechanism whereby CP alters the
replicase complex nor the alteration itself is understood.
The coat protein could change the structure of the com-
plex by protein–protein interactions as suggested by
Quadt et al. (1991), resulting in an enzyme that recog-
nizes the 39 ends of both positive- and negative-sense
templates; putative host components are likely to be
involved. Such a model suggests that the assembly of
stable replication complexes requires AMV RNA posi-
tive-strand 39 ends. Recently, van der Vossen reported
that minus-strand AMV RNA 3 is not infectious to plants
expressing preformed replicase containing P1 and P2
without CP (van der Vossen, 1996). Thus, the CP may
enable the complex to better recognize the minus-sense
templates or it may increase processivity of the complex
on minus-sense templates. The replication complex con-
sisting of P1, P2, and CP is more active than the complex
without CP and appears to synthesize fewer small tran-
scripts (de Graaff et al., 1995). Therefore, the addition of
AMV CP to the replication complex may result in efficient
synthesis of full-length virus RNAs for translation and
encapsidation.
MATERIALS AND METHODS
DNA constructs
The mutations at the N-terminus of AMV CP were intro-
duced using AMV subgenomic RNA4 cDNA, pSP65A4 (Loe-
sch-Fries et al., 1985), as the template for PCR (Yusibov and
Loesch-Fries, 1995). To change selected amino acids, NheI
and BsaI sites were introduced for cloning (Fig. 1). A
21-nucleotide first-strand primer consisting of 59-GAC-
CCGGGCATCCCTTAGGGG-39, which hybridizes to nucleo-
tides 867–881 of RNA4 cDNA (Loesch-Fries et al., 1985), and a
59-CTAAAGCTAGCCAGAACTATGCTGCC-39 second-strand
primer, which hybridizes to nucleotides 83–108, were used to
create an NheI restriction site (underlined) by changing the
nucleotides in bold type. This changed codon 18 from arginine
to alanine. The PCR product, pCPNheI, which lacked the first
82 nucleotides at the 59 end of RNA4, was cloned into the
pGEM-T vector (Promega, Madison, WI). To create cDNAs
containing an NheI site and coding for alanine at position 18,
or positions 18 and 14, or positions 17 and 18, first-strand
primers corresponding to 59-TTCTGGCTAGCTTTAGTAGGTT-
TACC-39, which hybridizes to nucleotides 73–98, 59-TTCTG-
GCTAGCTTTAGTAGGTGCACCAGCTTTCCC-39, which hybrid-
izes to nucleotides 64–98, or 59-TTCTGGCTAGCTGCAGTAG-
GTTTACC-39, which hybridizes to nucleotides 73–98,
respectively (nucleotide changes in bold type; restriction site
underlined), were used with a 24-nucleotide 59-CTTTGAAT-
TCGTTTTTATTTTTAA-39 second-strand primer, which hybrid-
izes to nucleotides 1–14 (Loesch-Fries et al., 1985), for PCR.
The resulting products, which correspond to the first 98 nucle-
otides at the 59 end of RNA4, were ligated with pCPNheI at the
NheI site to create full-length ORFs for mutant CPs. The EcoRI-
–BamHI fragments containing the mutations were exchanged
with the corresponding wild-type (wt) fragment in pSP65A4 to
create pCP18A, pCP14, 18A, and pCP17, 18A (Fig. 1). To create
a BsaI cloning site, PCR was performed using the 21-
nucleotide first-strand primer (Loesch-Fries et al., 1985) and a
59-CCTACTAAACGGTCTCAGAACTATGCT-39 second strand
primer, which hybridizes to nucleotides 79–105 and introduces
the restriction site (underlined) by nucleotide changes (bold
type) in the arginine 18 codon. The product, pCPBsaI, which
lacked 78 nucleotides of the 59 end of RNA4, was cloned into
the pGEM-T vector. To introduce single alanine substitutions at
position 14 or 17 along with the BsaI cloning site, cDNA was
amplified using 59-AGCATAGTTCTGAGACCGTTTAGTAGGT-
GCACCAGC-39, which hybridizes to nucleotides 70–105, or
59-AGCATAGTTCTGAGACCGTGCAGTAGG-39, which hybrid-
izes to nucleotides 79–105, as the first-strand primer (restric-
tion site underlined; nucleotide changes in bold type) and the
24-nucleotide second-strand primer (Loesch-Fries et al., 1985).
The PCR products, which correspond to the first 105 nucleo-
tides of the 59 end of RNA4, were ligated to pCPBsaI at the
BsaI site to create full-length ORFs for mutant CPs. The EcoRI–
BamHI fragments of these clones containing the mutations
were exchanged with the corresponding wt fragment in
pSP65A4 to create pCP14A, and pCP17A (Fig. 1). To confirm
that the desired changes were made, all mutants were
sequenced.
In vitro transcription and translation
In vitro transcripts of wt or mutant RNA4 were made
using SP6 polymerase (Promega, Madison, WI) and
respective cDNA linearized by SmaI (Loesch-Fries et
al., 1985). RNA cap structure analog [m7G(5)ppp(5)G,
Biolabs, Beverly, MA] was added to cap the transcripts
during synthesis. The messenger activity of the RNA
transcripts was determined by in vitro translation
(Davis and Kaesberg, 1973). Proteins were labeled
with [35S]Met in a wheat germ cell-free translation
system and separated by electrophoresis in a 13%
SDS–polyacrylamide gel followed by autoradiography
(Samac et al., 1983).
RNA isolation and Northern Analysis
AMV genomic RNA (RNA1, 2, 3) was isolated from
native virions (Loesch-Fries et al., 1985) and used for the
infection of protoplasts. AMV RNA accumulation in pro-
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toplasts was detected by Northern blot hybridization
(Loesch-Fries et al., 1987) using AMV cDNA probes. To
detect the relative percentage of RNA in samples, the
radioactivity in individual lanes of the Northern blot mem-
brane was determined using a LS5000CD liquid scintil-
lation system (Beckman, Palo Alto, CA).
Preparation, inoculation, and immunoassay
of protoplasts
Protoplasts were isolated from axenic tobacco plants
(Nicotiana tabacum var Xanthi-nc) as described (Loesch-
Fries et al., 1985) and inoculated with AMV genomic
RNAs (RNA1, 2, 3 mixture at 0.5 mg/105 protoplasts) alone
or in combination with wt or mutant transcripts of RNA4
(2 mg/105 protoplasts) using a polyethylene glycol proce-
dure (Samac et al., 1983). The protoplasts were collected
24 h after inoculation and assayed by immunofluores-
cence using monoclonal antibodies to AMV CP to deter-
mine the percentage of protoplasts that were infected
(Loesch-Fries and Hall, 1980).
Electrophoretic mobility shift assay (EMSA)
To test the binding of CP to AMV RNA, 2 pmol of
32P-labeled transcripts of RNA4 (composed of the 39 end
192 nucleotides) was combined with an aliquot of an in
vitro translation reaction containing 150,000 cpm of prod-
ucts synthesized from wt or mutant RNA4. The reaction
was incubated at room temperature for 10 min as de-
scribed by Baer et al. (1994) and the reaction products
were analyzed by electrophoresis in a 7.5% polyacryl-
amide gel (acrylamide:bis ratio of 46:1) in 44.5 mM Tris,
44.5 mM boric acid, 1.25 mM EDTA, pH 8.3.
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